Biography:
Dr. Qingyuan Yang studied Clinical Laboratory Diagnostics at the Tongji University, Shanghai, China and graduated as MD in 2014. She then worked in Shanghai Tenth People’s Hospital as a technician in charge in the department of molecular diagnostics during 2014 to 2018. Afterwards, she joined Dr. Willers Henning and Miyamoto David lab as a senior postdoctoral fellow in Massachusetts General Hospital of Harvard University School of Medicine, USA, during 2019 to 2021. She gained a position of a technician deputy director in Department of Pathology, Shanghai Ninth People’s Hospital of Shanghai Jiaotong University School of Medicine. She is now focusing on elaborating the underlying mechanisms of spatially targeted STING in the treatment of GBM and developing new strategies to precisely deliver its agonists without adverse events.
Title : STING is significantly increased in high-grade glioma with high risk of recurrence